Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus
  • Copilot
    Filings Search  
    Plans   
    Login   
    Register   
    Backtest Portfolio
    Portfolio Optimization
    Asset Correlations
    Efficient Frontier

    GNCA Current Ratio

    As of 2025-05-28, the Current Ratio of Genocea Biosciences Inc (GNCA) is 2.24.

    Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.

    GNCA Current Ratio - Historical Value
    DateValue
    2021-12-31 2.24
    2020-12-31 3.29
    2019-12-31 6.62
    2018-12-31 2.52
    2017-12-31 0.83
    2016-12-31 6.2
    -
    -
    -
    -
    GNCA Current Ratio - Peers Comparison
    TickerNameValue
    950160.KQKolon TissueGene Inc0.1
    950200.KQPsomagen Inc2.57
    950220.KQNeoimmunetech Inc5.61
    ABBVAbbvie Inc0.66
    AIMAIM ImmunoTech Inc1.68
    AMGNAmgen Inc1.26
    APMAptorum Group Ltd1.18
    ARMPArmata Pharmaceuticals Inc0.23
    BBLGBone Biologics Corp10.22
    CAPRCapricor Therapeutics Inc7.77
    CFRXContraFect Corp0.85
    CLRBCellectar Biosciences Inc2.58
    CLSNCelsion Corp7.67
    CTICCTI Biopharma Corp1.23
    CYTRCytRx Corp2.22
    EDT.TOSpectral Medical Inc0.16
    ELDNEledon Pharmaceuticals Inc12.42
    EQEquillium Inc3.93
    GALTGalectin Therapeutics Inc0.49
    GILDGilead Sciences Inc1.6
    GTBPGT Biopharma Inc0.72
    HTBXHeat Biologics Inc21.04
    IPIXInnovation Pharmaceuticals Inc0.33
    ISRIsoRay Inc19.86
    LMNLLiminal BioSciences Inc4.09
    LOGCLogicBio Therapeutics Inc31.2
    MBRXMoleculin Biotech Inc0.97
    MRNAModerna Inc3.67
    OGENOragenics Inc0.87
    REGNRegeneron Pharmaceuticals Inc4.73
    SIOXSio Gene Therapies Inc5.52
    SRRASierra Oncology Inc8.34
    SVRASavara Inc13.73
    VRTXVertex Pharmaceuticals Inc2.69
    VTVTvTv Therapeutics Inc7.34
    XYNOXynomic Pharmaceuticals Holdings Inc0.02
    Tickers added to watchlist